Publication | Closed Access
Double-Blind, Placebo-Controlled Study of the Efficacy of Reboxetine and Citalopram as Adjuncts to Atypical Antipsychotics for Negative Symptoms of Schizophrenia
20
Citations
32
References
2014
Year
ClinicalTrials.gov identifier: NCT01300364.
| Year | Citations | |
|---|---|---|
Page 1
Page 1